← all drugs
Methotrexate Sodium Injection
in shortage · Rheumatology · Snapshot: 2026-10-09
Day 1,306
of this shortage, counting from the FDA's first posting on 03/13/2023
- Manufacturers listed
- Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Teva Pharmaceuticals USA, Inc., Accord Healthcare Inc., Fresenius Kabi USA, LLC
- Reported reason(s)
- Demand increase for the drug; Other
- Machine-readable
- JSON for this drug
Presentations (14)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | 10/01/2026 |
| Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30) | Accord Healthcare Inc. | Unavailable | 10/03/2026 |
| Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | 10/01/2026 |
| Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35) | Accord Healthcare Inc. | Unavailable | 10/03/2026 |
| Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | 10/01/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-17 — Methotrexate Sodium Injection: availability wording revised for 1 presentation(s)
- 2026-09-05 — Methotrexate Sodium Injection: availability wording revised for 1 presentation(s)
- 2026-09-03 — Methotrexate Sodium Injection: availability wording revised for 5 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.